RGEN FY 2010 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

FY 2010 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$21M-28.6% YoY

Gross Profit

$15M73.7% margin

Operating Income

-$6M-27.5% margin

Net Income

-$4M-19.4% margin

EPS (Diluted)

$-0.13

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$71M

Total Liabilities

$5M

Stockholders' Equity

$67M

Cash & Equivalents

$13M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$29M	-28.6%
Gross Profit	$15M	$23M	-31.5%
Operating Income	-$6M	$4M	-248.6%
Net Income	-$4M	$6M	-170.7%